PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Brickell Biotech, Inc. (BBI)

Equity · Currency in USD · Last updated Dec 7, 2023
SummaryFinancials

Company Info

ISINUS10802T1051
CUSIP10802T105
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$6.75M
EPS-$0.42
Revenue (TTM)$4.64M
Gross Profit (TTM)-$27.83M
EBITDA (TTM)-$30.50M
Year Range$0.45 - $2.58
Target Price$17.83
Short %6.73%
Short Ratio0.62

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Brickell Biotech, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-99.99%
6.60%
BBI (Brickell Biotech, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BBI

Brickell Biotech, Inc.

Return

Brickell Biotech, Inc. had a return of -40.67% year-to-date (YTD) and -46.39% in the last 12 months. Over the past 10 years, Brickell Biotech, Inc. had an annualized return of -56.39%, while the S&P 500 had an annualized return of 9.70%, indicating that Brickell Biotech, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-40.67%18.49%
1 month0.39%4.20%
6 months53.42%6.60%
1 year-46.39%15.43%
5 years (annualized)-70.70%11.59%
10 years (annualized)-56.39%9.70%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20235.92%29.82%4.09%-12.33%51.56%-6.95%-6.38%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Brickell Biotech, Inc. (BBI) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
BBI
Brickell Biotech, Inc.
-0.44
^GSPC
S&P 500
1.00

Sharpe Ratio

The current Brickell Biotech, Inc. Sharpe ratio is -0.44. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
-0.44
1.00
BBI (Brickell Biotech, Inc.)
Benchmark (^GSPC)

Dividend History


Brickell Biotech, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-100.00%
-5.15%
BBI (Brickell Biotech, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Brickell Biotech, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Brickell Biotech, Inc. was 100.00%, occurring on May 9, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Feb 18, 20005842May 9, 2023
-65.29%Jun 12, 1996564Sep 3, 1998312Nov 30, 1999876
-59.37%Feb 3, 1994295Apr 5, 1995204Jan 25, 1996499
-29.05%Jan 29, 199652Apr 11, 199621May 10, 199673
-29.05%Jul 6, 199343Sep 3, 199326Oct 12, 199369

Volatility Chart

The current Brickell Biotech, Inc. volatility is 14.90%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
14.90%
2.92%
BBI (Brickell Biotech, Inc.)
Benchmark (^GSPC)